Vge Iii Portfolio Ltd. - Net Worth and Insider Trading

Vge Iii Portfolio Ltd. Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Vge Iii Portfolio Ltd. owns 8 companies in total, including Arbutus Biopharma Corp (ABUS) , Sio Gene Therapies Inc (SIOX) , and Myovant Sciences Ltd (MYOV) among others .

Click here to see the complete history of Vge Iii Portfolio Ltd.’s form 4 insider trades.

Insider Ownership Summary of Vge Iii Portfolio Ltd.

Ticker Comapny Transaction Date Type of Owner
ABUS Arbutus Biopharma Corp 2016-07-08 10 percent owner
SIOX Sio Gene Therapies Inc 2016-07-08 10 percent owner
MYOV Myovant Sciences Ltd 2016-10-26 10 percent owner
LIMIT LIMIT 2019-07-10 other: Former 10% Owner
LIMIT LIMIT 2019-06-26 10 percent owner
LIMIT LIMIT 2016-04-13 10 percent owner
LIMIT LIMIT 2016-02-08 10 percent owner
LIMIT LIMIT 2014-10-01 10 percent owner

Vge Iii Portfolio Ltd. Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Vge Iii Portfolio Ltd. Ownership Network

Ownership Network List of Vge Iii Portfolio Ltd.

No Data

Ownership Network Relation of Vge Iii Portfolio Ltd.

Insider Network Chart

Vge Iii Portfolio Ltd. Owned Company Details

What does Arbutus Biopharma Corp do?

Who are the key executives at Arbutus Biopharma Corp?

Vge Iii Portfolio Ltd. is the 10 percent owner of Arbutus Biopharma Corp. Other key executives at Arbutus Biopharma Corp include Chief Financial Officer David C Hastings , Chief Business Officer Michael J. Mcelhaugh , and Chief Scientific Officer Michael J. Sofia .

Arbutus Biopharma Corp (ABUS) Insider Trades Summary

Over the past 18 months, Vge Iii Portfolio Ltd. made no insider transaction in Arbutus Biopharma Corp (ABUS). Other recent insider transactions involving Arbutus Biopharma Corp (ABUS) include a net sale of 10,164 shares made by Michael J. Mcelhaugh , a net sale of 9,982 shares made by Michael J. Sofia , and a net sale of 9,593 shares made by David C Hastings .

In summary, during the past 3 months, insiders sold 8,846 shares of Arbutus Biopharma Corp (ABUS) in total and bought 0 shares, with a net sale of 8,846 shares. During the past 18 months, 42,943 shares of Arbutus Biopharma Corp (ABUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 42,943 shares.

Arbutus Biopharma Corp (ABUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Arbutus Biopharma Corp Insider Transactions

No Available Data

Vge Iii Portfolio Ltd. Mailing Address

Above is the net worth, insider trading, and ownership report for Vge Iii Portfolio Ltd.. You might contact Vge Iii Portfolio Ltd. via mailing address: C/o Morgan Stanley Fund Srvcs (cayman), Cricket Sq, Hutchins Dr, Po Box 2681, Grand Cayman E9 Ky1-1111.